Mileutis Receives 2025 AgTech Breakthrough Award for Antibiotic-Free Dairy Therapy

Mileutis, a leading ag-biotech company, has been honored with the 2025 AgTech Breakthrough Award for its dairy productivity solution IMILAC, a milk-derived therapy that strengthens cows' natural immune systems to prevent and treat mastitis without antibiotics. The award recognizes the product's significant impact on sustainable agriculture through its residue-free approach that improves milk yield, enhances milk quality, and reduces waste from discarded milk while addressing the critical global challenge of antimicrobial resistance.

David Javier Iscovich, CEO of Mileutis, emphasized that this recognition marks a milestone for the company and demonstrates the power of science-driven innovation in agriculture. The therapy represents a sustainable alternative to commonly used antibiotic and hormone treatments, offering dairy farmers a path to higher productivity and healthier herds. According to the company, IMILAC has undergone more than a decade of research into naturally occurring milk peptides and their ability to activate cows' immune defenses, providing a natural solution that protects animal health without compromising productivity.

The AgTech Breakthrough Awards program honors excellence and innovation across agricultural technology, specifically recognizing companies and products that are transforming the industry through sustainable, impactful solutions. Dr. Jose Iscovich, Chief Scientific Officer at Mileutis, explained that by replacing antibiotics with this natural approach, the company can help slow the spread of resistant bacteria while driving sustainability within the dairy industry. For additional information about the company and its innovations, visit https://www.mileutis.com.

This award underscores the growing importance of developing alternatives to antibiotics in animal agriculture, particularly as concerns about antimicrobial resistance continue to escalate globally. The recognition highlights how innovative biologic therapies can simultaneously address multiple challenges facing modern dairy farming, including animal welfare concerns, productivity demands, and environmental sustainability requirements. The development of such solutions represents a significant step forward in creating more resilient and responsible food production systems.